CAUSEY CHRISTOPHER

PrivateCIK: 1237334

Senior insider sale

UNITED THERAPEUTICS CORP — senior position signals high conviction

$2.33M

4.32K shares

What this filing means

CAUSEY CHRISTOPHER plans to sell 4.32K shares of UNITED THERAPEUTICS CORP valued at approximately $2.33M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderCAUSEY CHRISTOPHERCIK 1237334
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Director
Since Mar 2026
4.32K
Shares to sell
$2.33M
Approx. market value
1.30K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Sort

Stock Option Exercise

Cash

3/30/2026
1.30K
Total acquired1.30K
Planned & Completed Dispositions5
Sort

Completed

Completed

Units to sell

20.00

Market value

$9.8K

3/4/2026
Completed

Units to sell

1K

Market value

$520.0K

2/25/2026
Completed

Units to sell

1K

Market value

$510.0K

1/6/2026
Completed

Units to sell

1K

Market value

$500.0K

1/2/2026

Planned — Approximate Date

NASDAQPlanned

Units to sell

1.30K

Market value

$786.0K

3/30/2026
Total

Units

4.32K

Value

$2.33M

CAUSEY CHRISTOPHER — Planned Insider Sale (Form 144) | Finecho